256 related articles for article (PubMed ID: 35274325)
1. Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
Zamani M; Alizadeh-Tabari S; Singh S; Loomba R
Aliment Pharmacol Ther; 2022 Apr; 55(8):894-907. PubMed ID: 35274325
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study.
Abenavoli L; Spagnuolo R; Scarlata GGM; Scarpellini E; Boccuto L; Luzza F
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38003983
[No Abstract] [Full Text] [Related]
3. Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease.
Zou ZY; Shen B; Fan JG
Inflamm Bowel Dis; 2019 Oct; 25(11):1764-1772. PubMed ID: 30918952
[TBL] [Abstract][Full Text] [Related]
4. The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis.
Noorian S; Jeon Y; Nguyen MT; Sauk J; Limketkai BN
Inflamm Bowel Dis; 2022 Jun; 28(6):878-887. PubMed ID: 34374782
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history.
Magrì S; Paduano D; Chicco F; Cingolani A; Farris C; Delogu G; Tumbarello F; Lai M; Melis A; Casula L; Fantini MC; Usai P
World J Gastroenterol; 2019 Oct; 25(37):5676-5686. PubMed ID: 31602167
[TBL] [Abstract][Full Text] [Related]
6. Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease.
Hyun HK; Lee HW; Park J; Park SJ; Park JJ; Kim TI; Lee JS; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU; Cheon JH
Gut Liver; 2024 Mar; 18(2):294-304. PubMed ID: 37203442
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease.
Navarro P; Gutiérrez-Ramírez L; Tejera-Muñoz A; Arias Á; Lucendo AJ
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960160
[TBL] [Abstract][Full Text] [Related]
8. Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease.
Martínez-Domínguez SJ; García-Mateo S; Gargallo-Puyuelo CJ; Gallego Llera B; Refaie E; Callau P; Mendi C; Baptista PM; Hernández Ainsa M; Arroyo-Villarino MT; López de la Cruz J; Martínez-García J; Alfambra E; Simón Marco MÁ; Ampuero J; Gomollón F
Eur J Intern Med; 2024 Feb; 120():99-106. PubMed ID: 37872034
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
Yen HH; Su PY; Huang SP; Wu L; Hsu TC; Zeng YH; Chen YY
PLoS One; 2021; 16(5):e0252286. PubMed ID: 34043691
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
Sourianarayanane A; Garg G; Smith TH; Butt MI; McCullough AJ; Shen B
J Crohns Colitis; 2013 Sep; 7(8):e279-85. PubMed ID: 23158500
[TBL] [Abstract][Full Text] [Related]
11. Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: a systematic review.
Spagnuolo R; Abenavoli L; Corea A; Larussa T; Mancina RM; Cosco C; Luzza F; Doldo P
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5818-5825. PubMed ID: 34604973
[TBL] [Abstract][Full Text] [Related]
12. Crohn's Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
Aggarwal M; Garg R; Parthasarthy G; Nowacki AS; Padival R; McCullough A; Qazi T; Click B; Rieder F; Cohen BL
Dig Dis Sci; 2023 Mar; 68(3):1006-1015. PubMed ID: 35731428
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors.
Principi M; Iannone A; Losurdo G; Mangia M; Shahini E; Albano F; Rizzi SF; La Fortezza RF; Lovero R; Contaldo A; Barone M; Leandro G; Ierardi E; Di Leo A
Inflamm Bowel Dis; 2018 Jun; 24(7):1589-1596. PubMed ID: 29688336
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Lin A; Roth H; Anyane-Yeboa A; Rubin DT; Paul S
Inflamm Bowel Dis; 2021 May; 27(6):947-955. PubMed ID: 32780094
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
Bessissow T; Le NH; Rollet K; Afif W; Bitton A; Sebastiani G
Inflamm Bowel Dis; 2016 Aug; 22(8):1937-44. PubMed ID: 27379445
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
Carr RM; Patel A; Bownik H; Oranu A; Kerner C; Praestgaard A; Forde KA; Reddy KR; Lichtenstein GR
Dig Dis Sci; 2017 May; 62(5):1354-1361. PubMed ID: 28265826
[TBL] [Abstract][Full Text] [Related]
17. Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review.
Martínez-Domínguez SJ; García-Mateo S; Laredo V; Gargallo-Puyuelo CJ; Gallego Llera B; López de la Cruz J; Gomollón F
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444477
[TBL] [Abstract][Full Text] [Related]
18. Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography.
Saroli Palumbo C; Restellini S; Chao CY; Aruljothy A; Lemieux C; Wild G; Afif W; Lakatos PL; Bitton A; Cocciolillo S; Ghali P; Bessissow T; Sebastiani G
Inflamm Bowel Dis; 2019 Jan; 25(1):124-133. PubMed ID: 29889226
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis.
Hoffmann P; Jung V; Behnisch R; Gauss A
World J Gastroenterol; 2020 Dec; 26(46):7367-7381. PubMed ID: 33362390
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together.
Maresca R; Mignini I; Varca S; Calvez V; Termite F; Esposto G; Laterza L; Scaldaferri F; Ainora ME; Gasbarrini A; Zocco MA
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
